• Home
  • Category: Pulmonary Medicine

JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis

SARS-CoV-2 has already infected over 63 million people worldwide. Janus kinase-inhibitors and Type I interferons have emerged as potential antiviral c...

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomized, controlled, open-label, adaptive platform trial

Azithromycin, an antibiotic with potential antiviral and anti-inflammatory properties, has been used to treat COVID-19. Evidence from community random...

The impact of coronavirus disease 2019 (COVID-19) on liver injury in China: A systematic review and meta-analysis

Evidence for the incidence and severity of liver injury in Chinese patients with coronavirus disease 2019 (COVID-19) is still controversial. Computer...

Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients

Coronavirus disease 2019 started to spread globally in December 2019 from Wuhan, China. Fever has been observed as one of the most common clinical man...

Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms

4/49, 8.2% were positive for SARS-CoV-2 RNA. The median duration of illness when the first conjunctival swab was obtained was 10 days (range 2-27 days...

A pandemic center's experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study

SARS-CoV-2 was suspected in 100 pregnant women. Of them, 29 had the diagnosis confirmed by RT-PCR. Eight of the remaining 71 cases had clinical findin...

SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March-May 2020

UK implemented a lockdown in March 2020, when the testing policy at the time was focusing on hospitalized cases. We assessed COVID-19 point prevalence...

Early Risk Factors for the Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Positivity in Patients With Coronavirus Disease 2019

Pneumonia coronavirus disease 2019 (COVID-19) has become a pandemic. Early risk factors for the duration of SARS-CoV-2 viral positivity were evaluated...

Departments

Recent Posts